Quintet Private Bank Europe S.A. Increases Stock Position in Colgate-Palmolive (NYSE:CL)

Quintet Private Bank Europe S.A. boosted its stake in Colgate-Palmolive (NYSE:CLFree Report) by 9.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,776 shares of the company’s stock after purchasing an additional 400 shares during the quarter. Quintet Private Bank Europe S.A.’s holdings in Colgate-Palmolive were worth $381,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Union Savings Bank raised its position in shares of Colgate-Palmolive by 76.6% during the 4th quarter. Union Savings Bank now owns 309 shares of the company’s stock valued at $25,000 after buying an additional 134 shares in the last quarter. Avion Wealth raised its position in shares of Colgate-Palmolive by 78.1% during the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after buying an additional 175 shares in the last quarter. Atlantic Edge Private Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive during the 4th quarter valued at about $32,000. Core Wealth Advisors Inc. raised its position in shares of Colgate-Palmolive by 56.6% during the 4th quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock valued at $32,000 after buying an additional 146 shares in the last quarter. Finally, McGlone Suttner Wealth Management Inc. purchased a new stake in shares of Colgate-Palmolive during the 4th quarter valued at about $34,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. StockNews.com cut shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 20th. Barclays upped their price target on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the company an “equal weight” rating in a report on Tuesday, April 30th. Stifel Nicolaus upped their price target on shares of Colgate-Palmolive from $94.00 to $95.00 and gave the company a “buy” rating in a report on Monday, April 29th. Citigroup upped their price target on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, April 16th. Finally, Royal Bank of Canada upped their price target on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a report on Monday, April 29th. Three research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $92.94.

Check Out Our Latest Research Report on CL

Insider Activity at Colgate-Palmolive

In related news, insider Sally Massey sold 12,226 shares of the stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the sale, the insider now owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Colgate-Palmolive news, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the transaction, the insider now owns 3,181 shares of the company’s stock, valued at $297,328.07. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the transaction, the insider now directly owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Stock Down 0.1 %

Shares of NYSE CL traded down $0.14 during midday trading on Friday, reaching $94.62. 2,722,828 shares of the company’s stock traded hands, compared to its average volume of 3,539,232. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 13.21. The stock’s 50 day simple moving average is $91.70 and its 200-day simple moving average is $86.21. Colgate-Palmolive has a one year low of $67.62 and a one year high of $95.59. The company has a market cap of $77.63 billion, a price-to-earnings ratio of 29.94, a P/E/G ratio of 3.48 and a beta of 0.39.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The firm had revenue of $5.07 billion for the quarter, compared to the consensus estimate of $4.96 billion. During the same period last year, the firm earned $0.73 earnings per share. The company’s quarterly revenue was up 6.2% on a year-over-year basis. On average, analysts predict that Colgate-Palmolive will post 3.53 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.11%. Colgate-Palmolive’s dividend payout ratio is presently 63.29%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.